Publications by authors named "Randolph D Andrews"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

17

Total Likes

2

Extended Reach

6,176

Social Features

2
D
Development, initial validation, and application of a visual read method for [F]MK-6240 tau PET.
Joanna L Shuping, Dawn C Matthews, Katarzyna Adamczuk, David Scott, Christopher C Rowe, William C Kreisl, Sterling C Johnson, Ana S Lukic, Keith A Johnson, Pedro Rosa-Neto

Alzheimers Dement (N Y)· February 2023

Videos about Article: user

1 1 2

View All Article and Social Media Activity
E
EC images reveal reproducible spatial variation in drug affinity across single- and repeat-dose occupancy studies.
Alaaddin Ibrahimy, Su Jin Kim, Mark E Schmidt, Mark Slifstein, Erik Mannaert, Randolph D Andrews

J Cereb Blood Flow Metab· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationships between plasma biomarkers, tau PET, FDG PET, and volumetric MRI in mild to moderate Alzheimer's disease patients.
Dawn C Matthews, Jefferson W Kinney, Aaron Ritter, Randolph D Andrews, Erin N Toledano Strom

Alzheimers Dement (N Y)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurement of neurodegeneration using a multivariate early frame amyloid PET classifier.
Dawn C Matthews, Ana S Lukic, Randolph D Andrews, Miles N Wernick, Stephen C Strother

Alzheimers Dement (N Y)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Riluzole, a glutamate modulator, slows cerebral glucose metabolism decline in patients with Alzheimer's disease.
Dawn C Matthews, Xiangling Mao, Kathleen Dowd, Diamanto Tsakanikas, Caroline S Jiang, Randolph D Andrews

Brain· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rasagiline effects on glucose metabolism, cognition, and tau in Alzheimer's dementia.
Dawn C Matthews, Aaron Ritter, Ronald G Thomas, Randolph D Andrews, Ana S Lukic

Alzheimers Dement (N Y)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDG PET Parkinson's disease-related pattern as a biomarker for clinical trials in early stage disease.
Dawn C Matthews, Hedva Lerman, Ana Lukic, Randolph D Andrews, Anat Mirelman

Neuroimage Clin· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations of lifestyle and vascular risk factors with Alzheimer's brain biomarker changes during middle age: a 3-year longitudinal study in the broader New York City area.
Michelle J Walters, Joanna Sterling, Crystal Quinn, Christine Ganzer, Ricardo S Osorio, Randolph D Andrews

BMJ Open· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PET Imaging of Tau Pathology and Relationship to Amyloid, Longitudinal MRI, and Cognitive Change in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI).
Michael S Rafii, Ana S Lukic, Randolph D Andrews, James Brewer, Robert A Rissman

J Alzheimers Dis· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dissociation of Down syndrome and Alzheimer's disease effects with imaging.
Dawn C Matthews, Ana S Lukic, Randolph D Andrews, Boris Marendic, James Brewer

Alzheimers Dement (N Y)· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An evaluation of MSDC-0160, a prototype mTOT modulating insulin sensitizer, in patients with mild Alzheimer's disease.
Raj C Shah, Dawn C Matthews, Randolph D Andrews, Ana W Capuano, Debra A Fleischman

Curr Alzheimer Res· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physical Activity, Mediterranean Diet and Biomarkers-Assessed Risk of Alzheimer's: A Multi-Modality Brain Imaging Study.
Dawn C Matthews, Michelle Davies, John Murray, Schantel Williams, Wai H Tsui, Randolph D Andrews

Adv J Mol Imaging· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing brain amyloid deposition, glucose metabolism, and atrophy in mild cognitive impairment with and without a family history of dementia.
Lisa Mosconi, Randolph D Andrews, Dawn C Matthews

J Alzheimers Dis· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-dependent effects of the CRF(1) receptor antagonist R317573 on regional brain activity in healthy male subjects.
Mark E Schmidt, Randolph D Andrews, Peter van der Ark, Terry Brown, Erik Mannaert

Psychopharmacology (Berl)· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis